ISSN: 2155-9899
Department of Public Health and Family Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi
Research Article
Assessing the Fidelity of the Malaria Vaccine Implementation in Malawi
Author(s): Parth K. Patel*
Globally, remarkable progress has been made in the fight against malaria over the last two decades, yet the
rate of reduction of malaria case incidence and mortality seems stalled. Globally, malaria case incidence
(i.e., cases per 1000 population at risk) reduced from 80 to 58 and only to 57 in 2019. Mosquirix (RTS,
S/AS01), a four-dose malaria vaccine with an effectiveness of 39%, was piloted by the WHO in three
countries including Malawi where it was integrated into the EPI as a regular schedule dose. Fidelity was
assessed to evaluate the degree of adherence to the planned protocol for the roll out of the program.
This is a qualitative study that used the implementation fidelity framework where 12 healthcare workers
were interviewed, 47 parents attended 2 focused group discussions, and a non-participatory observation
checklist determined the status of vaccine.. View More»
DOI:
10.35248/2155-9899.23.14.697